Abstract
Gaochen Lu, Chenchen Liang
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Ulcerative colitis: epidemiology, diagnosis, and management [J
10.1016/j.mayocp.2014.07.002 · 2014
10.1016/s0140-6736(16)32126-2
10.1016/s0140-6736(16)32126-2
10.1136/gutjnl-2018-318131
10.1136/gutjnl-2018-318131
10.1136/gutjnl-2013-304833
10.1136/gutjnl-2013-304833
10.1038/ajg.2013.4
10.1038/ajg.2013.4
Washed microbiota transplantation for Clostridioides difficile infection: a national multicenter real-world study
10.1111/1751-2980.13227 · 2023
10.1097/cm9.0000000000002339
10.1097/cm9.0000000000002339
Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening
10.1007/s13238-019-00684-8 · 2020
Nanjing consensus on methodology of washed microbiota transplantation
10.1097/cm9.0000000000000954 · 2020
10.1111/1751-7915.14074
10.1111/1751-7915.14074
Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial
10.1136/gutjnl-2022-327811 · 2022
Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial
10.1001/jama.2018.20046 · 2019
Efficacy and safety of fecal microbiota transplantation by washed preparation in patients with moderate to severely active ulcerative colitis
10.1111/1751-2980.12938 · 2020
Long-term safety and efficacy of fecal microbiota transplant in active ulcerative colitis
10.1007/s40264-019-00809-2 · 2019
Exploration of potential gut microbiota-derived biomarkers to predict the success of fecal microbiota transplantation in ulcerative colitis: a prospective cohort in Korea
10.5009/gnl210369 · 2022
Older patients benefit more from sequential courses of washed microbiota transplantation than younger population with ulcerative colitis
2023
Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery
2022
Colonic transendoscopic enteral tubing is a new pathway to microbial therapy, colonic drainage, and host-microbiota interaction research
2023
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
10.1016/s2468-1253(22)00022-x · 2022
Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies
10.1016/j.cgh.2013.09.060 · 2014
Scikit-learn: machine learning in python
2011
tableone: an open source Python package for producing summary statistics for research papers
10.1093/jamiaopen/ooy012 · 2018
10.1148/radiology.148.3.6878708
10.1148/radiology.148.3.6878708
10.1186/s12880-015-0068-x
10.1186/s12880-015-0068-x
10.1016/j.jclinepi.2009.11.009
10.1016/j.jclinepi.2009.11.009
10.1038/s41551-018-0304-0
10.1038/s41551-018-0304-0
10.1053/j.gastro.2018.12.001
10.1053/j.gastro.2018.12.001
Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis
10.1016/j.ebiom.2022.104088 · 2022
The underlying changes in serum metabolic profiles and efficacy prediction in patients with extensive ulcerative colitis undergoing fecal microbiota transplantation
2023
Biomarkers of inflammation in inflammatory bowel disease
10.1053/j.gastro.2015.07.003 · 2015
10.1186/s12967-015-0646-2
10.1186/s12967-015-0646-2
Prognostic value of fecal calprotectin to inform treat-to-target monitoring in ulcerative colitis
10.1016/j.cgh.2022.07.027 · 2023
Artificial intelligence for inflammatory bowel diseases (IBD); accurately predicting adverse outcomes using machine learning
10.1007/s10620-022-07506-8 · 2022
Short-term surveillance of cytokines and c-reactive protein cannot predict efficacy of fecal microbiota transplantation for ulcerative colitis
10.1371/journal.pone.0158227 · 2016
10.1136/gutjnl-2018-317263
10.1136/gutjnl-2018-317263
Acetylcholinesterase inhibitor pyridostigmine bromide attenuates gut pathology and bacterial dysbiosis in a murine model of ulcerative colitis
10.1007/s10620-019-05838-6 · 2020
10.2169/internalmedicine.46.0237
10.2169/internalmedicine.46.0237
10.1097/meg.0000000000001466
10.1097/meg.0000000000001466
10.1371/journal.pone.0179267
10.1371/journal.pone.0179267
Association between serum bilirubin and mucosal healing among Japanese patients with ulcerative colitis: a cross-sectional study
10.1007/s00384-020-03774-w · 2021
Concept, breakthrough, and future of colonic transendoscopic enteral tubing
10.1097/cm9.0000000000003020 · doi-reference
Fecal microbiota transplantation through transendoscopic enteral tubing for inflammatory bowel disease: high acceptance and high satisfaction
10.1111/jgh.16435 · doi-reference
Targeted modulation of intestinal epithelial regeneration and immune response in ulcerative colitis using dual-targeting bilirubin nanoparticles
10.7150/thno.87739 · doi-reference
The association between bilirubin concentrations and inflammatory bowel disease: insights from a systematic review and meta-analysis
10.1111/eci.14281 · doi-reference